US biotech sector poised for 2026 rebound as IPO interest revives
By Sriparna Roy and Christy Santhosh Jan 14 (Reuters) – Investors are eyeing a rebound in the U.S. biotech sector…
By Sriparna Roy and Christy Santhosh Jan 14 (Reuters) – Investors are eyeing a rebound in the U.S. biotech sector…